General counsel in the US have come under fire in the past week as the authorities continue to exert regulatory pressure on companies.

Last week pharmaceutical giant Bristol-Myers Squibb announced it had parted company with its general counsel, Richard Willard, following an investigation into the negotiation of a settlement agreement. This related to litigation concerning the use of a drug manufactured by Bristol-Myers.